| Denise Mary Fitzgerald, LCSW | |
|
2205 Phyllis St, Bentonville, AR 72712-6490 | |
| (479) 750-2020 | |
| (479) 845-2109 |
| Full Name | Denise Mary Fitzgerald |
|---|---|
| Gender | Female |
| Speciality | Social Worker - Clinical |
| Location | 2205 Phyllis St, Bentonville, Arkansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1669415139 | NPI | - | NPPES |
| 5X504 | Other | AR | BLUE SHIELD PROVIDER # |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | 1761-C (Arkansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Denise Mary Fitzgerald, LCSW Po Box 6430, Springdale, AR 72766-6430 Ph: (479) 750-2020 | Denise Mary Fitzgerald, LCSW 2205 Phyllis St, Bentonville, AR 72712-6490 Ph: (479) 750-2020 |
News Archive
Staphylococcus aureus (Sa) and methicillin-resistant staph aureus (MRSA) continue to be among the most common pathogens that overwhelm the immune system, causing serious skin, soft tissue and life-threatening blood-borne infections.
ARIAD Pharmaceuticals, Inc. today announced that following a priority review, the U.S. Food and Drug Administration (FDA) has granted accelerated approval of Iclusig (ponatinib) for the treatment of adult patients with chronic, accelerated or blast phase chronic myeloid leukemia (CML) that is resistant or intolerant to prior tyrosine kinase inhibitor (TKI) therapy or Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) that is resistant or intolerant to prior TKI therapy.
Experts say at least $20 million to $30 million in government research is needed over the next decade to adequately identify and address the possible ecological risks of synthetic biology, an emerging area of research focused on the design and construction of new biological parts and systems, or modification of existing ones, to create new applications in areas ranging from energy to chemicals and pharmaceuticals.
Ob-gyns are uniquely positioned to play a major role in reducing the effects of toxic chemicals on women and babies, according to an analysis led by University of California, San Francisco (UCSF) researchers.
› Verified 2 days ago
Stephanie Litzinger, LCSW Clinical Social Worker Medicare: May Accept Medicare Assignments Practice Location: 2508 Se 20th St, Bentonville, AR 72712 Phone: 479-750-2020 Fax: 479-750-4843 | |
Sharon A Odom, LCSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 2508 Se 20th St, Bentonville, AR 72712 Phone: 479-273-9088 Fax: 479-750-4843 | |
Keisha Kennedy, PLMSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 602 N Walton Blvd, Bentonville, AR 72712 Phone: 870-394-4643 Fax: 870-394-4646 | |
Holly Fleming, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 803 Se Plaza Ave Ste 1, Bentonville, AR 72712 Phone: 479-362-5724 | |
Austin Oslica, PLMSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 2003 Se Walton Blvd, Bentonville, AR 72712 Phone: 479-725-6000 Fax: 479-750-4843 | |
Douglas Spencer Monson, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 2003 Se Walton Blvd, Suite C, Bentonville, AR 72712 Phone: 479-464-8081 Fax: 479-464-0674 | |
Laura Fox, Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 2805 Mid Cities Dr Ste 1, Bentonville, AR 72712 Phone: 479-271-7634 Fax: 479-271-7654 |